DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Tokyo Big Sight

2018 年 11 月 11 日 9:30 上午 - 2018 年 11 月 13 日 5:40 下午

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V8-S6] Approaches to Implement Revision for New Format Labeling and Discussion How to Provide Information by Other Materials

Session Chair(s)

Takashi  Ohira

Takashi Ohira

Associate Director, Safety Management, Pharmacovigilance Department

Takeda Pharmaceutical Company Limited, Japan

In April 2019 official guidelines for new format of labeling will be enforced. Prior to that, PMDA consultation with some drugs to align with the new guidelines was started from July this year (first wave), and feedback from PMDA has been notified each company. Based on the disclosure of labeling of some model drugs, we introduce examples of them and discuss case studies and initiatives concerning tasks until actual implementation of revision of the labeling of the new guideline. Also, we would like to discuss contrivances in thinking about effective information provision with other materials such as interview form based on new format of labeling, and viewpoints from healthcare providers as readers of new format of labeling and points to note when providing information.

Speaker(s)

Akifumi  Kamata, PhD

Official Guidelines for New Format of Labeling and Findings of First Wave of Consultation for Labelling Revision

Akifumi Kamata, PhD

Pharmaceuticals and Medical Devices Agency, Japan

Office of New Drug I

Tatsumi  Inamura

Provision of Approaches to Implement Revision for New Format of Labeling from the Pharmaceutical Industry Perspective

Tatsumi Inamura

Novartis Pharma K.K., Japan

Group Manager, Prescribing Information Group, RA Functions Department

Hideo  Nakada, RPh

Provision of Approaches to Implement Revision for New Format of Labeling from Pharmacist of Medical Institute Perspective

Hideo Nakada, RPh

Keio University, Japan

Deputy Associate Manager, Department of Hospital Pharmacy

Shinya  Takemoto, MSc

Provision with Other Materials such as Interview Form based on New Format of Labeling and Providing Information

Shinya Takemoto, MSc

Chugai Pharmaceutical Co., Ltd., Japan

Group Manager, Safety Information Strategy Group, Risk Communication Department

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。